TrialClinical trialPHN-02572026-05-11 19:00 CT
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
Source · ClinicalTrials.gov: survodutide
TLDR
A ClinicalTrials.gov listing describes an active, non-recruiting study comparing survodutide with semaglutide in adults aged 18–65 with obesity. The randomized study tests whether survodutide improves energy use and fat breakdown, with participants followed for 8–10 months.
01—Key points
- 01Participants are randomly assigned to survodutide or semaglutide.
- 02Researchers measure energy expenditure using oxygen intake and carbon dioxide output and monitor unwanted effects.
- 03The excerpt describes the study design but reports no results.
Why it matters Editorial
The study could provide comparative evidence on energy use and fat breakdown with survodutide versus semaglutide in people with obesity.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
02—Related news
Article
PHN-0003
2026-10-28 16:12 CT